Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national results on adolescent drug use: Overview of key findings, 2010. Ann Arbor, MI: Institute for Social Research, The University of Michigan, 2011.
Sustance Abuse and Mental Health Services Adminstration. The NSDUH Report: Trends in Adolescent Substance Use and Perception of Risk from Substance Use. Sustance Abuse and Mental Health Services Adminstration: Rockville, MD; 2013.
Eaton DK, Kann L, Kinchen S, et al. Youth Behavior Surveillance—United States, 2011. Atlanta, GA: CDC; 2012.
U.S. Department of Health and Human Services, Sustance Abuse and Mental Health Services Adminstration. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Sustance Abuse and Mental Health Services Adminstration; 2011.
Merikangas KR, Nakamura EF, Kessler RC. Epidemiology of mental disorders in children and adolescents. Dialogues Clin Neurosci. 2009; 11(1): 7–20.
Armstrong TD, Costello EJ. Community studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity. J COnsult Clin Psychol. 2002; 70(6): 1224–1239.
Arnett JJ. Adolescent storm and stress, reconsidered. Am Psychol. 1999; 54(5): 317–326.
Dahl RE. Adolescent brain development: a period of vulnerabilities and opportunities. Keynote address. Ann N Y Acad Sci. 2004; 1021: 1–22.
Ernst M, Pine DS, Hardin M. Triadic model of the neurobiology of motivated behavior in adolescence. Psychol Med. 2006; 36(3): 299–312.
Nelson EE, Leibenluft E, McClure EB, Pine DS. The social re-orientation of adolescence: a neuroscience perspective on the process and its relation to psychopathology. Psychol Med. 2005; 35(2): 163–174.
Steinberg L. Risk taking in adolescence: what changes, and why?
Ann N Y Acad SciAnn N Y Acad Sci. 2004; 1021: 51–58.
Ernst M, Hale E, O’Connell K. Response to commentaries regarding the Triadic Systems Model perspective. Brain Cogn. 2014; 89: 122–126.
Arnett JJ. G. Stanley Hall’s Adolescence: brilliance and nonsense. Hist Psychol. 2006; 9(3): 186–197.
Hall G. Adolescence: Its Psychology and Its Relations to Physiology, Anthropology, Sociology, Sex, Crime, Religion and Education. New York: Appleton; 1904.
Spear LP. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev. 2000; 24(4): 417–463.
Ernst M, Romeo RD, Andersen SL. Neurobiology of the development of motivated behaviors in adolescence: a window into a neural systems model. Pharmacol Biochem Behav. 2009; 93(3): 199–211.
Wahlstrom D, Collins P, White T, Luciana M. Developmental changes in dopamine neurotransmission in adolescence: behavioral implications and issues in assessment. Brain Cogn. 2010; 72(1): 146–159.
Robbins TW, Everitt BJ. Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol. 1996; 6(2): 228–236.
Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology. 2010; 35(1): 217–238.
Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci. 2011; 12(11): 652–669.
Garavan H, Weierstall K. The neurobiology of reward and cognitive control systems and their role in incentivizing health behavior. Prev Med. 2012; 55(Suppl): S17–S23.
Wise RA, Rompre PP. Brain dopamine and reward. Annu Rev Psychol. 1989; 40: 191–225.
Wise RA. Neurobiology of addiction. Curr Opin Neurobiol. 1996; 6(2): 243–251.
Volkow ND, Fowler JS, Wang GJ. The addicted human brain: insights from imaging studies. J Clin Invest. 2003; 111(10): 1444–1451.
Luciana M, Wahlstrom D, Porter JN, Collins PF. Dopaminergic modulation of incentive motivation in adolescence: age-related changes in signaling, individual differences, and implications for the development of self-regulation. Dev Psychol. 2012; 48(3): 844–861.
Carlsson A, Lindqvist M, Magnusson T. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature. 1957; 180(4596): 1200.
Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev. 2011; 63(1): 182–217.
Bjorklund A, Dunnett SB. Dopamine neuron systems in the brain: an update. Trends Neurosci. 2007; 30(5): 194–202.
Moore H, West AR, Grace AA. The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia. Biol Psychiatry. 1999; 46(1): 40–55.
Nemoda Z, Szekely A, Sasvari-Szekely M. Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood. Neurosci Biobehav Rev. 2011; 35(8): 1665–1686.
Joyce JN. Multiple dopamine receptors and behavior. Neurosci Biobehav Rev. 1983; 7(2): 227–256.
Kohno M, Ghahremani DG, Morales AM, et al. Risk-taking behavior: dopamine D2/D3 receptors, feedback, and frontolimbic activity. Cereb Cortex. 2015; 25(1): 236–245.
Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev. 1998; 78(1): 189–225.
Floresco SB, Magyar O. Mesocortical dopamine modulation of executive functions: beyond working memory. Psychopharmacology (Berl). 2006; 188(4): 567–585.
Depue RA, Collins PF. Neurobiology of the structure of personality: dopamine, facilitation of incentive motivation, and extraversion. Behav Brain Sci. 1999; 22(3): 491–517; discussion 518–569.
Swanson LW. The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull. 1982; 9(1–6): 321–353.
Kaczmarek LK, Levitan I. Neuromodulation: The Biochemical Control of Neuronal Excitability. Oxford, England: Oxford University Press; 1987.
Trudeau LE. Glutamate co-transmission as an emerging concept in monoamine neuron function. J Psychiatry Neurosci. 2004; 29(4): 296–310.
Luciana M, Collins PF. Incentive motivation, cognitive control, and the adolescent brain: is it time for a paradigm shift?
Child Dev Perspect. 2012; 6(4): 392–399.
Garris PA, Rebec GV. Modeling fast dopamine neurotransmission in the nucleus accumbens during behavior. Behav Brain Res. 2002; 137(1–2): 47–63.
Rice ME, Cragg SJ. Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway. Brain Res Rev. 2008; 58(2): 303–313.
Floresco SB, West AR, Ash B, Moore H, Grace AA. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nature Neurosci. 2003; 6(9): 968–973.
Goto Y, Otani S, Grace AA. The yin and yang of dopamine release: a new perspective. Neuropharmacology. 2007; 53(5): 583–587.
Grace AA, Bunney BS. The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci. 1984; 4(11): 2877–2890.
Grace AA, Bunney BS. The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci. 1984; 4(11): 2866–2876.
Wanat MJ, Willuhn I, Clark JJ, Phillips PE. Phasic dopamine release in appetitive behaviors and drug addiction. Curr Drug Abuse Rev. 2009; 2(2): 195–213.
Willuhn I, Wanat MJ, Clark JJ, Phillips PE. Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse. Curr Top Behav Neurosci. 2010; 3: 29–71.
Schultz W. Multiple reward signals in the brain. Nat Rev Neurosci. 2000; 1(3): 199–207.
Niv Y, Joel D, Dayan P. A normative perspective on motivation. Trends Cogn Sci. 2006; 10(8): 375–381.
Niv Y, Daw ND, Joel D, Dayan P. Tonic dopamine: opportunity costs and the control of response vigor. Psychopharmacology (Berl). 2007; 191(3): 507–520.
Ostlund SB, Wassum KM, Murphy NP, Balleine BW, Maidment NT. Extracellular dopamine levels in striatal subregions track shifts in motivation and response cost during instrumental conditioning. J Neurosci. 2011; 31(1): 200–207.
Wahlstrom D, White T, Luciana M. Neurobehavioral evidence for changes in dopamine system activity during adolescence. Neurosci Biobehav Rev. 2010; 34(5): 631–648.
Andersen SL, Dumont NL, Teicher MH. Developmental differences in dopamine synthesis inhibition by (+/-)-7-OH-DPAT. Naunyn Schmiedebergs Arch Pharmacol. 1997; 356(2): 173–181.
Gelbard HA, Teicher MH, Faedda G, Baldessarini RJ. Postnatal development of dopamine D1 and D2 receptor sites in rat striatum. Brain Res Dev Brain Res. 1989; 49(1): 123–130.
Tarazi FI, Tomasini EC, Baldessarini RJ. Postnatal development of dopamine D1-like receptors in rat cortical and striatolimbic brain regions: an autoradiographic study. Dev Neurosci. 1999; 21(1): 43–49.
Teicher MH, Andersen SL, Hostetter JC Jr. Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Brain Res Dev Brain Res. 1995; 89(2): 167–172.
Giorgi O, De Montis G, Porceddu ML, et al. Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum. Brain Res. 1987; 432(2): 283–290.
Leslie CA, Robertson MW, Cutler AJ, Bennett JP Jr. Postnatal development of D1 dopamine receptors in the medial prefrontal cortex, striatum and nucleus accumbens of normal and neonatal 6-hydroxydopamine treated rats: a quantitative autoradiographic analysis. Brain Res Dev Brain Res. 1991; 62(1): 109–114.
Tarazi FI, Tomasini EC, Baldessarini RJ. Postnatal development of dopamine D4-like receptors in rat forebrain regions: comparison with D2-like receptors. Brain Res Dev Brain Res. 1998; 110(2): 227–233.
Rao PA, Molinoff PB, Joyce JN. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Brain Res Dev Brain Res. 1991; 60(2): 161–177.
Goto Y, Grace AA. Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior. Nat Neurosci. 2005; 8(6): 805–812.
Jia JM, Zhao J, Hu Z, Lindberg D, Li Z. Age-dependent regulation of synaptic connections by dopamine D2 receptors. Nat Neurosci. 2013; 16(11): 1627–1636.
Crews F, He J, Hodge C. Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behav. 2007; 86(2): 189–199.
Selemon LD. A role for synaptic plasticity in the adolescent development of executive function. Transl Psychiatry. 2013; 3: e238.
Selemon LD. Frontal lobe synaptic plasticity in development and disease: modulation by the dopamine d1 receptor. Curr Pharm Des. 2014; 20(32): 5194–5201.
Sun X, Zhao Y, Wolf ME. Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons. J Neurosci. 2005; 25(32): 7342–7351.
Auclair N, Otani S, Soubrie P, Crepel F. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J Neurophysiol. 2000; 83(6): 3287–3293.
Pascual M, Boix J, Felipo V, Guerri C. Repeated alcohol administration during adolescence causes changes in the mesolimbic dopaminergic and glutamatergic systems and promotes alcohol intake in the adult rat. J Neurochem. 2009; 108(4): 920–931.
McCutcheon JE, Conrad KL, Carr SB, Ford KA, McGehee DS, Marinelli M. Dopamine neurons in the ventral tegmental area fire faster in adolescent rats than in adults. J Neurophysiol. 2012; 108(6): 1620–1630.
Harden KP, Tucker-Drob EM. Individual differences in the development of sensation seeking and impulsivity during adolescence: further evidence for a dual systems model. Dev Psychol. 2011; 47(3): 739–746.
Steinberg L, Albert D, Cauffman E, Banich M, Graham S, Woolard J. Age differences in sensation seeking and impulsivity as indexed by behavior and self-report: evidence for a dual systems model. Dev Psychol. 2008; 44(6): 1764–1778.
Urosevic S, Collins P, Muetzel R, Lim K, Luciana M. Longitudinal changes in behavioral approach system sensitivity and brain structures involved in reward processing during adolescence. Dev Psychol. 2012; 48(5): 1488–1500.
Bjork JM, Pardini DA. Who are those “risk-taking adolescents”? Individual differences in developmental neuroimaging research. Dev Cogn Neurosci. 2015; 11: 56–64.
Richards JM, Plate RC, Ernst M. A systematic review of fMRI reward paradigms used in studies of adolescents vs. adults: the impact of task design and implications for understanding neurodevelopment. Neurosci Biobehav Rev. 2013; 37(5): 976–991.
Joel D, Weiner I. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience. 2000; 96(3): 451–474.
Cohen JR, Asarnow RF, Sabb FW, et al. A unique adolescent response to reward prediction errors. Nat Neurosci. 2010; 13(6): 669–671.
Di Chiara G. Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol. 1999; 375(1–3): 13–30.
Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A. 1988; 85(14): 5274–5278.
Fiorino DF, Coury A, Phillips AG. Dynamic changes in nucleus accumbens dopamine efflux during the Coolidge effect in male rats. J Neurosci. 1997; 17(12): 4849–4855.
Grace AA. The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction. 2000; 95(Suppl 2): S119–S128.
Mastwal S, Ye Y, Ren M, et al. Phasic dopamine neuron activity elicits unique mesofrontal plasticity in adolescence. J Neurosci. 2014; 34(29): 9484–9496.
Howe MW, Tierney PL, Sandberg SG, Phillips PE, Graybiel AM. Prolonged dopamine signalling in striatum signals proximity and value of distant rewards. Nature. 2013; 500(7464): 575–579.
Kolb B. Brain plasticity and behavioral change. In: Craik F, Robert M, Sabourin M, eds. Advances in Psychological Science, Volume 2: Biological and Cognitive Aspects. East Sussex, UK: Psychology Press; 1998.
Robinson TE, Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci. 1997; 17(21): 8491–8497.
Volkow ND, Fowler JS, Gatley SJ, et al. PET evaluation of the dopamine system of the human brain. J Nucl Med. 1996; 37(7): 1242–1256.
Mizrahi R. Advances in PET analyses of stress and dopamine. Neuropsychopharmacology. 2010; 35(1): 348–349.
Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry. 2005; 57(3): 229–238.
D’Ardenne K, McClure SM, Nystrom LE, Cohen JD. BOLD responses reflecting dopaminergic signals in the human ventral tegmental area. Science. 2008; 319(5867): 1264–1267.
Eapen M, Zald DH, Gatenby JC, Ding Z, Gore JC. Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system. AJNR Am J Neuroradiol. 2011; 32(4): 688–694.
Sustance Abuse and Mental Health Services Adminstration. Results from the 2005 National Survey on Drug Use and Health: National Findings. Rockville, MD: Office of Applied Studies; 2006. DHHS Publication No. SMA 06-4194.
Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. New Engl J Med. 2014; 370(23): 2219–2227.
Gorelick DA, Levin KH, Copersino ML, et al. Diagnostic criteria for cannabis withdrawal syndrome. Drug Alcohol Depend. 2012; 123(1–3): 141–147.
Oleson EB, Cheer JF. A brain on cannabinoids: the role of dopamine release in reward seeking. Cold Spring Harb Perspect Med. 2012; 2: 1–13.
Schweinsburg AD, Brown SA, Tapert SF. The influence of marijuana use on neurocognitive functioning in adolescents. Curr Drug Abuse Rev. 2008; 1(1): 99–111.
Puig MV, Rose J, Schmidt R, Freund N. Dopamine modulation of learning and memory in the prefrontal cortex: insights from studies in primates, rodents, and birds. Front Neural Circuits. 2014; 8: 93.
Burns HD, Van Laere K, Sanabria-Bohorquez S, et al. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc Natl Acad Sci U S A. 2007; 104(23): 9800–9805.
Gilman JM, Kuster JK, Lee S, et al. Cannabis use is quantitatively associated with nucleus accumbens and amygdala abnormalities in young adult recreational users. J Neurosci. 2014; 34(16): 5529–5538.
Dennison M, Whittle S, Yucel M, et al. Mapping subcortical brain maturation during adolescence: evidence of hemisphere- and sex-specific longitudinal changes. Dev Sci. 2013; 16(5): 772–791.
Ostby Y, Tamnes CK, Fjell AM, Westlye LT, Due-Tonnessen P, Walhovd KB. Heterogeneity in subcortical brain development: a structural magnetic resonance imaging study of brain maturation from 8 to 30 years. J Neurosci. 2009; 29(38): 11772–11782.
Schneider S, Peters J, Bromberg U, et al. Risk taking and the adolescent reward system: a potential common link to substance abuse. Am J Psychiatry. 2012; 169(1): 39–46.
Urošević S, Collins P, Muetzel R, Lim KO, Luciana M. Pubertal status associations with reward and threat sensitivities and subcortical brain volumes during adolescence. Brain Cogn. 2014; 89: 15–26.
Arnone D, Barrick TR, Chengappa S, Mackay CE, Clark CA, Abou-Saleh MT. Corpus callosum damage in heavy marijuana use: preliminary evidence from diffusion tensor tractography and tract-based spatial statistics. Neuroimage. 2008; 41(3): 1067–1074.
Ashtari M, Cervellione K, Cottone J, Ardekani BA, Sevy S, Kumra S. Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use. J Psychiatr Res. 2009; 43(3): 189–204.
Gruber SA, Dahlgren MK, Sagar KA, Gonenc A, Lukas SE. Worth the wait: effects of age of onset of marijuana use on white matter and impulsivity. Psychopharmacology (Berl). 2014; 231(8): 1455–1465.
Gruber SA, Silveri MM, Dahlgren MK, Yurgelun-Todd D. Why so impulsive? White matter alterations are associated with impulsivity in chronic marijuana smokers. Exp Clin Psychopharmacol. 2011; 19(3): 231–242.
Heimer L, Alheid GF. Piecing together the puzzle of basal forebrain anatomy. Adv Exp Med Biol. 1991; 295: 1–42.
Kolb B, Gorny G, Limebeer CL, Parker LA. Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats. Synapse. 2006; 60(6): 429–436.
Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Goudriaan AE. Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Neuroimage. 2012; 59(4): 3845–3851.
Lorenzetti V, Lubman DI, Whittle S, Solowij N, Yucel M. Structural MRI findings in long-term cannabis users: what do we know?
Subst Use Misuse. 2010; 45(11): 1787–1808.
Jager G, Ramsey NF. Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: an overview of animal and human research. Curr Drug Abuse Rev. 2008; 1(2): 114–123.
Batalla A, Bhattacharyya S, Yucel M, et al. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS One. 2013; 8(2): e55821.
Volkow ND, Wang GJ, Telang F, et al. Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity. Proc Natl Acad Sci U S A. 2014; 111(30): E3149–E3156.
Albrecht DS, Skosnik PD, Vollmer JM, et al. Striatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users. Drug Alcohol Depend. 2013; 128(1–2): 52–57.
Sevy S, Smith GS, Ma Y, et al. Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography. Psychopharmacology (Berl). 2008; 197(4): 549–556.
Stokes PR, Egerton A, Watson B, et al. History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability. J Psychopharmacol. 2012; 26(1): 144–149.
Urban NB, Slifstein M, Thompson JL, et al. Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study. Biol Psychiatry. 2012; 71(8): 677–683.
Bloomfield MA, Morgan CJ, Kapur S, Curran HV, Howes OD. The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study. Psychopharmacology (Berl). 2014; 231(11): 2251–2259.
Murray JE, Dilleen R, Pelloux Y, et al. Increased impulsivity retards the transition to dorsolateral striatal dopamine control of cocaine seeking. Biol Psychiatry. 2014; 76(1): 15–22.
Nestor L, Hester R, Garavan H. Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users. Neuroimage. 2010; 49(1): 1133–1143.
van Hell HH, Vink M, Ossewaarde L, Jager G, Kahn RS, Ramsey NF. Chronic effects of cannabis use on the human reward system: an fMRI study. Eur Neuropsychopharmacol. 2010; 20(3): 153–163.
Sneider JT, Mashhoon Y, Silveri MM. A review of magnetic resonance spectroscopy studies in marijuana using adolescents and adults. J Addict Res Ther. 2013; Suppl 4.
Silveri MM, Jensen JE, Rosso IM, Sneider JT, Yurgelun-Todd DA. Preliminary evidence for white matter metabolite differences in marijuana-dependent young men using 2D J-resolved magnetic resonance spectroscopic imaging at 4 Tesla. Psychiatry Res. 2011; 191(3): 201–211.
Hermann D, Sartorius A, Welzel H, et al. Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users. Biol Psychiatry. 2007; 61(11): 1281–1289.
Chang L, Cloak C, Yakupov R, Ernst T. Combined and independent effects of chronic marijuana use and HIV on brain metabolites. J Neuroimmune Pharmacol. 2006; 1(1): 65–76.
Muetzel RL, Marjanska M, Collins PF, et al. In vivo H magnetic resonance spectroscopy in young-adult daily marijuana users. Neuroimage Clin. 2013; 2: 581–589.
Prescot AP, Locatelli AE, Renshaw PF, Yurgelun-Todd DA. Neurochemical alterations in adolescent chronic marijuana smokers: a proton MRS study. Neuroimage. 2011; 57(1): 69–75.
Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. American J Psychiatry. 2005; 162(8): 1403–1413.
Hakamata Y, Lissek S, Bar-Haim Y, et al. Attention bias modification treatment: a meta-analysis toward the establishment of novel treatment for anxiety. Biol Psychiatry. 2010; 68(11): 982–990.
Field M, Marhe R, Franken IH. The clinical relevance of attentional bias in substance use disorders. CNS Spectr. 2014; 19(3): 225–230.
Sample S, Kadden R. Motivational Enhancement Therapy and Cognitive Behavioral Therapy for Adolescent Cannabis Users: 5 Sessions. Rockville, MD: Center for Substance Abuse Treatment; 2001.
Dennis M, Titus JC, Diamond G, et al. The Cannabis Youth Treatment (CYT) experiment: rationale, study design and analysis plans. Addiction. 2002; 97(Suppl 1): 16–34.
Dennis M, Godley SH, Diamond G, et al. The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials. J Subst Abuse Treat. 2004; 27(3): 197–213.